Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07156201
PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Given Orally Compared With Placebo in Healthy Participants Aged 18 to 55 Years

Sponsor: Actio Biosciences, Inc.

View on ClinicalTrials.gov

Summary

This first in human trial will evaluate the safety, tolerability, and pharmacokinetics of single ascending doses, multiple ascending doses, and fed and fasted doses of ABS-1230 given orally compared with placebo in adult healthy participants.

Official title: A First-in-Human, Phase 1a, Randomized, Double-Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose and Food Effect Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABS-1230 Administered Orally to Healthy Adults

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

74

Start Date

2025-08-28

Completion Date

2026-03

Last Updated

2025-11-26

Healthy Volunteers

Yes

Interventions

DRUG

ABS-1230

ABS-1230

DRUG

Placebo

Placebo

DRUG

Omeprazole

Omeprazole

Locations (1)

Scientia Clinical Research

Sydney, New South Wales, Australia